High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9662|135|1|55-64

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.1, 2015-0, pp. : 55-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post‐remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: A retrospective analysis of the Rete Ematologica Lombarda

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : E123-E125

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Intensity Induction in the Elderly

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 53-54

Karger

Access to resources Recommend Favorite

Selection of Elderly Acute Myeloid Leukemia Patients for Intensive Chemotherapy: Effectiveness of Intensive Chemotherapy and Subgroup Analysis

By  

Acta Haematologica, Vol. 133, Iss. 3, 2014-12 ,pp. : 300-309

Karger

Access to resources Recommend Favorite

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 796-799

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 639-646

John Wiley & Sons Inc

Access to resources Recommend Favorite